These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 21612354)

  • 41. Combination antiplatelet agents for secondary prevention of ischemic stroke.
    Vande Griend JP; Saseen JJ
    Pharmacotherapy; 2008 Oct; 28(10):1233-42. PubMed ID: 18823219
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Don't use aspirin for primary prevention of cardiovascular disease.
    Barnett H; Burrill P; Iheanacho I
    BMJ; 2010 Apr; 340():c1805. PubMed ID: 20410163
    [No Abstract]   [Full Text] [Related]  

  • 43. Aspirin for primary prevention of cardiovascular disease in women: does sex matter?
    Hung J
    Med J Aust; 2006 Mar; 184(6):260-1. PubMed ID: 16548826
    [TBL] [Abstract][Full Text] [Related]  

  • 44. New guidelines for the prevention of recurrent stroke. Updated recommendations can help people who have had a stroke or TIA lessen their chances of another "brain attack".
    Harv Heart Lett; 2014 Aug; 24(12):6. PubMed ID: 25230422
    [No Abstract]   [Full Text] [Related]  

  • 45. Cardiovascular disease prevention using fixed dose pharmacotherapy in Iran: updated meta-analyses and mortality estimation.
    Sepanlou SG; Farzadfar F; Jafari E; Danaei G
    Arch Iran Med; 2012 Sep; 15(9):531-7. PubMed ID: 22924369
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Aspirin for the Primary Prevention of Cardiovascular Disease: A Review of the Literature and Considerations for Clinical Practice.
    Cicci JD; Iyer P; Clarke MM; Mazzella AJ
    Cardiol Rev; 2020; 28(2):98-106. PubMed ID: 31764014
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Aspirin Primary Prevention Conundrum.
    Schamroth Pravda M; Schamroth Pravda N; Beigel Y; Matetzky S; Beigel R
    Isr Med Assoc J; 2020 Jan; 22(1):60-63. PubMed ID: 31927808
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Aspirin for primary prevention: Is this the end of the road?
    Singal AK; Karthikeyan G
    Indian Heart J; 2019; 71(2):113-117. PubMed ID: 31280821
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Aspirin for primary prevention of cardiovascular events in the elderly: current status and future directions.
    Ward SA; Demos L; Workman B; McNeil JJ
    Drugs Aging; 2012 Apr; 29(4):251-8. PubMed ID: 22462627
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The aspirin in reducing events in the elderly trial: Statistical analysis plan.
    Wolfe R; Murray AM; Woods RL; Kirpach B; Gilbertson D; Shah RC; Nelson MR; Reid CM; Ernst ME; Lockery J; Donnan GA; Williamson J; McNeil JJ
    Int J Stroke; 2018 Apr; 13(3):335-338. PubMed ID: 29111960
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Secondary Prevention of Childhood Arterial Ischemic Stroke.
    Darteyre S; Renaud C; Fluss J; Laporte S; Bertoletti L; Chabrier S
    J Child Neurol; 2017 Apr; 32(5):488-493. PubMed ID: 28128037
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Aspirin in primary prevention of cardiovascular events in women and men (a meta-analysis of randomized controlled trials)].
    Iavelov IS
    Kardiologiia; 2006; 46(3):75-6. PubMed ID: 16710263
    [No Abstract]   [Full Text] [Related]  

  • 53. Use of a Geographic Information System to create treatment groups for group-randomized community trials: The Minnesota Heart Health Program.
    Krzyzanowski B; Manson SM; Eder MM; Kne L; Oldenburg N; Peterson K; Hirsch AT; Luepker RV; Duval S
    Trials; 2019 Mar; 20(1):185. PubMed ID: 30922358
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A health-economic evaluation of aspirin: primary prevention and cardiovascular disease.
    Sakai T; Saku K
    Intern Med; 2007; 46(8):431-3. PubMed ID: 17443030
    [No Abstract]   [Full Text] [Related]  

  • 55. Salicylate:aspirin ratios: relevance to aspirin's antithrombotic action.
    Philp RB; O'Kruk RJ; Paul ML
    Prostaglandins Leukot Med; 1984 May; 14(2):287-8. PubMed ID: 6429673
    [No Abstract]   [Full Text] [Related]  

  • 56. Estrogen and stroke: a balanced analysis.
    Hurn PD; Brass LM
    Stroke; 2003 Feb; 34(2):338-41. PubMed ID: 12574529
    [No Abstract]   [Full Text] [Related]  

  • 57. Prevention. Aspirin in primary prevention--good news and bad news.
    Hennekens CH; Baigent C
    Nat Rev Cardiol; 2012 Feb; 9(5):262-3. PubMed ID: 22371106
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Response to Commentary for 'Efficacy and safety of aspirin for primary prevention of cardiovascular events: a meta-analysis and trial sequential analysis of randomized controlled trials'.
    Mahmoud AN; Gad MM; Elgendy AY; Elgendy IY; Bavry AA
    Eur Heart J; 2019 Sep; 40(34):2924-2925. PubMed ID: 31005974
    [No Abstract]   [Full Text] [Related]  

  • 59. [Aspirin and primary prevention of vascular diseases in women].
    Laguta PS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; Suppl 15():79-84. PubMed ID: 16447559
    [No Abstract]   [Full Text] [Related]  

  • 60. Nutritional recommendations for the prevention of ischemic stroke.
    Rotilio G; Berni Canani R; Barba G; Branca F; Cairella G; Dilaghi B; Fieschi C; Garbagnati F; Gentile MG; Gensini GF; Gualtieri A; Inzitari D; La Massa M; Luisi ML; Mancia G; Marcelli M; Masini ML; Mastrilli F; Paolucci S; Pratesi L; Rubba P; Sacchetti ML; Salvia A; Scalfi L; Scognamiglio U; Siani A; Strazzullo P;
    Nutr Metab Cardiovasc Dis; 2004 Apr; 14(2):115-20. PubMed ID: 15242244
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.